February 25, 2021
Business News

Shareholder Alert: Robbins LLP Announces That Decision Diagnostics Corp. (DECN) is Being Sued for Misleading Shareholders

SAN DIEGO & WESTLAKE, Calif.–()–Shareholder rights law firm Robbins LLP announces that a purchaser of Decision Diagnostics Corp. (OTC: DECN) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between March 3, 2020 and December 17, 2020. Decision Diagnostics offers prescription and non-prescription diagnostics and homes testing products.

If you suffered a loss due to Decision Diagnostics Corp.’s misconduct, click here.

Decision Diagnostics Corp. (DECN) Misled Shareholders Regarding the Availability of its Blood Test to Detect COVID-19

According to the complaint, throughout the relevant period, defendants claimed that…

Click here to view the original article.

Related Posts

You might also like ...

Domtar Corporation Announces Management Committee Appointments
Waters and TetraScience Partner to Deliver New Levels of Data Access and Insights with Empower Data Science Link
AON Splash Image
Galaxy Entertainment Group Reports Q4 & Annual 2020 Results